Fundraising Fox

Flagshipbio

Westminster, US · 1 known investors

flagshipbio.com

Flagship Biosciences is a CLIA-certified, CAP-accredited spatial biology and biomarker services company that combines AI-powered tissue analysis with scientific consultation. It serves pharmaceutical and biotech companies in drug development and diagnostics.

AI & Machine LearningBiotechDigital HealthHealthtech

Founders & leadership

DN
Dean NortheyNamed on SEC filing
GD
G. David YoungNamed on SEC filing
TJ
Trevor JohnsonNamed on SEC filing
NA
Nancy A. GillettNamed on SEC filing
GM
Gary M. ClarkNamed on SEC filing
GK
Gregory K. TuckerNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$26.8M disclosed across 5 rounds · 2018–2024

$5MraisedApr 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul KirchgraberDirector
  • Trevor JohnsonExecutive Officer, Director
  • Tom TuriExecutive Officer, Director
  • Herb HooperDirector
  • William SniderDirector
Offering amount
$6.4M
Amount sold
$5M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedFeb 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Trevor JohnsonExecutive Officer, Director
  • Paul KirchgraberDirector
  • William SniderDirector
  • Tom TuriDirector
  • Herb HooperDirector
Offering amount
$5M
Amount sold
$3M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15.3MraisedSep 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Trevor JohnsonExecutive Officer, Director
  • Bill SniderDirector
  • Fisher AaronDirector
  • Herb H. HooperDirector
  • Tom TuriDirector
Offering amount
$15.3M
Amount sold
$15.3M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.5MraisedJul 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joe KrugerExecutive Officer
  • Nancy GillettDirector
  • Trevor JohnsonExecutive Officer, Director, Promoter
  • G. David YoungExecutive Officer, Director, Promoter
  • Gary ClarkDirector
  • L. Dean NortheyExecutive Officer
  • Holger LangeExecutive Officer
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedMar 2018 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dean NortheyExecutive Officer
  • G. David YoungExecutive Officer, Director, Promoter
  • Trevor JohnsonExecutive Officer, Director, Promoter
  • Nancy A. GillettDirector
  • Gary M. ClarkDirector
  • Gregory K. TuckerDirector
Offering amount
$1M
Amount sold
$1M
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Flagshipbio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Flagshipbio do?
Flagship Biosciences is a CLIA-certified, CAP-accredited spatial biology and biomarker services company that combines AI-powered tissue analysis with scientific consultation. It serves pharmaceutical and biotech companies in drug development and diagnostics.
Who are Flagshipbio's investors?
Flagshipbio's investors include Ampersand.
How much funding has Flagshipbio raised?
Flagshipbio has disclosed $26.8M raised across 5 rounds.
Where is Flagshipbio headquartered?
Flagshipbio is headquartered in Westminster, US.